XD华润双 (600062)

China Resources Double-crane Pharmaceutical Co., Ltd.

ASH

Tags

AI HealthcareDeepSeekMSCI Mid Cap IndexNicotinamide Mononucleotide (NMN) ConceptSSE Corporate Governance IndexCSI Central State-Owned Enterprises IndexGeneric DrugsWeight Loss DrugsInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareSynthetic BiologyGuozheng Value IndexSmall Cap ValueBiological VaccinesHigh-Performing StocksMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 103875.75
  • Circulating A-Shares(W): 103263.08
  • Earnings Per Share(RMB): 1.3077
  • Net Assets Per Share(RMB): 10.8962
  • Operating Revenue(W RMB): 828322.24
  • Total Profit(W RMB): 162085.41
  • **Net Profit Attributable to Parent(W RMB) **: 134953.55
  • Net Profit Growth Rate(%): -3.40
  • Weighted Return on Equity(%): 12.3400
  • Operating Cash Flow Per Share(RMB): 1.1040
  • Undistributed Profit Per Share(RMB): 9.7282
  • Capital Reserve Per Share(RMB): 0.1958

2. Main Business

The main business covers:

  • Processing and manufacturing of formulated drugs
  • Chemical and biological pharmaceutical raw materials
  • Pharmaceutical packaging materials

3. Company Basic Information

  • Company Name: China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Listing Date: 1997-05-22
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1 Lize East Second Road, Wangjing, Chaoyang District, Beijing
  • Website: https://www.dcpc.com/
  • Company Profile: The company was established on March 2, 1997, jointly initiated by Beijing Pharmaceutical Factory and others, with part of its assets converted into 89.5 million state shares and 10.5 million privately placed initiator legal person shares. After the issuance in May of the same year, the total share capital at the time of listing reached 147 million shares. Its 4.7 million internal employee shares will be listed for trading six months after the 42.3 million public shares were listed on May 22, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Beijing Pharmaceutical Group Co., Ltd. General Legal Person 62579.56 60.60
2 Hong Kong Securities Clearing Company Limited Northbound Capital 929.33 0.90
3 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 607.38 0.59
4 China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Renqiao Zeyuan Stock Private Securities Investment Fund Private Securities Investment Fund 247.37 0.24
5 China Life Insurance Company Limited - Traditional - General Insurance Products - 005L-CT001 Shanghai General Legal Person 195.54 0.19
6 HSBC Jintrust Value Pioneer Stock Securities Investment Fund Class A Fund 24.19 0.02
7 Dongxing Dividend Preferred Hybrid Securities Investment Fund Class A Fund 4.20 0.00
8 Xinyuan Medical Care Select Hybrid Initiation Securities Investment Fund Class A Fund 2.79 0.00

5. Concept Sectors

  • Biological Vaccines
  • Generic Drugs
  • NMN Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • DeepSeek
  • AI Healthcare

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information